MiR-200c-3p as a Novel Genetic Marker and Therapeutic Tool for Alopecia Areata

This study identifies hsa-miR-200c-3p as a potential genetic marker and therapeutic tool for alopecia areata (AA), involving 65 AA patients and 65 healthy controls. It reveals significantly higher levels of hsa-miR-200c-3p in AA patients, suggesting its link to AA development. The miRNA shows high diagnostic precision with an AUC of 0.885 and a sensitivity of 80.5% at a threshold of 1.8. Bioinformatic analysis identifies target genes like RPS6KB1 and CDH11, with pathway analysis indicating their role in AA development. The study emphasizes hsa-miR-200c-3p's involvement in biological pathways, suggesting its potential as a therapeutic target and recommending further research with larger samples.